Back to search

Japan· JP-3221001X1012

ヨウ化カリウム

A potassium iodide product containing ヨウ化カリウム, registered in Japan, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.

On Japan’s NHI price listATC R05CA02

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedヨウ化カリウムATCR05CA02REGISTER NO.JP-3221001X1012PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Potassium iodide is registered in 4 of 19 countries.

Countries holding a registration under ATC R05CA02 (potassium iodide), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 1 of them publish a price we can compare per daily dose

Potassium iodide · ATC R05CA02

4 / 19 countries

  • Germany
  • Japan
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ヨウ化カリウム
Manufacturer
—
Country
Japan (JP)
ATC code
R05CA02
ATC class
Potassium iodide
Defined daily dose
1.2 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

45 interactions on record for potassium iodide.

Graded by severity as the source publishes them — 19 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Potassium iodide · interactions on record

45 records

  • 19 severe
  • 26 moderate

Most severe, free to view

  • EplerenoneC03DA04severe
  • CaptoprilC09AA01severe
  • EnalaprilC09AA02severe
  • LisinoprilC09AA03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Potassium iodide in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All potassium iodide products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Jodid, Kaliumiodid Serb
  • Belgium · Iodure De Potassium Serb, Kaliumjodid Serb
  • Bulgaria · Калиев Йодид G.L. Pharma, Калиев Йодид Serb
  • Cyprus · Potassium Iodide G.L. Pharma, Yodafar
  • Czechia · Jodid, Jodid Draselný
  • Germany · Iodid Bc, Jodetten
  • Denmark · Kaliumiodid Serb
  • Estonia · Kaaliumjodiid Serb, Potassium Iodide G.L. Pharma
  • Spain · Yodafar, Yoduk
  • Finland · Jodix, Kaliumjodidi G.L. Pharma
  • France · Iodure De Potassium Pharmacie Centrale Des Armees, Iodure De Potassium Serb
  • United Kingdom (Northern Ireland) · Potassium Iodide G.L. Pharma, Potassium Iodide Serb
  • Croatia · Kalijev Jodid Sandoz
  • Hungary · Jodid, Kálium-Jodid Ep
  • Ireland · Potassium Iodide G.L. Pharma
  • Iceland · Kalíumjoðíð G.L. Pharma
  • Italy · Ioduro Di Potassio Serb
  • Lithuania · Kalio Jodidas Serb, Potassium Iodide G.L. Pharma
  • Luxembourg · Iodure De Potassium Serb, Jodid
  • Latvia · Potassium Iodide G.L. Pharma, Potassium Iodide Serb
  • Malta · Potassium Iodide G.L. Pharma, Yodafar
  • Netherlands · Kajodan, Kaliumjodide G.L.
  • Norway · Jodix, Kaliumjodid Serb
  • Poland · Jodek Potasu, Jodek Potasu G.L. Pharma
  • Portugal · Iodeto De Potássio Gl Pharma, Yodafar
  • Romania · Iodur? De Potasiu G.L. Pharma, Iodura De Potasiu Atb
  • Sweden · Kaliumjodid G.L. Pharma, Kaliumjodid Serb
  • Slovenia · Kalijev Jodid G.L. Pharma, Kalijev Jodid Lek
  • Slovakia · Jodid Draselný G. L. Pharma, Jodid Draselný Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6e58d234-924c-4788-9c2f-8c6537860e45
GET /v1/drugs/6e58d234-924c-4788-9c2f-8c6537860e45?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "1g",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "3221001X1012",
  "category": "内用薬",
  "price_yen": null,
  "generic_name": "ヨウ化カリウム",
  "product_name_jp": null,
  "therapeutic_class": "3221",
  "transitional_expiry": null
}

See everything about potassium iodide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.